Below you will find Medicines Optimisation position statements published by Frimley ICB. These have been written mindful of our priority to purchase those medicines and treatments that are proven to work well, can demonstrate an improvement in people's health and offer good value for money.  ICBs understand that there will be times when a patient may benefit from a treatment not usually given by the NHS. Visit the Individual Funding Requests website  for more information.

]]> https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies?format=html Thu, 20 Nov 2025 12:20:00 +0000 en-GB hourly 1 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3703-sermog-09-high-cost-immunomodulator-drug-pathway-for-adults-with-psoriatic-arthritis?format=html SERMOG-09 High-cost immunomodulator drug pathway for adults with psoriatic arthritis https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3703-sermog-09-high-cost-immunomodulator-drug-pathway-for-adults-with-psoriatic-arthritis?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Thu, 20 Nov 2025 12:20:00 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3702-sermog-08-anti-cgrp-and-botulinum-toxin-type-a-migraine-prevention-pathway?format=html SERMOG-08 Anti-CGRP and botulinum toxin type A migraine prevention pathway https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3702-sermog-08-anti-cgrp-and-botulinum-toxin-type-a-migraine-prevention-pathway?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Thu, 20 Nov 2025 12:17:55 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3701-sermog-06-inflammatory-bowel-disease-ibd-high-cost-drug-pathway-for-adults?format=html SERMOG-06 Inflammatory bowel disease (IBD) high cost drug pathway for adults https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3701-sermog-06-inflammatory-bowel-disease-ibd-high-cost-drug-pathway-for-adults?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Thu, 20 Nov 2025 12:16:50 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3700-sermog-05-high-cost-drugs-for-adults-with-juvenile-idiopathic-arthritis-jia?format=html SERMOG-05 High-cost drugs for adults with juvenile idiopathic arthritis (JIA) https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3700-sermog-05-high-cost-drugs-for-adults-with-juvenile-idiopathic-arthritis-jia?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Thu, 20 Nov 2025 12:14:32 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3694-position-statement-enteral-feed-tender-nhs-frimley-and-nhs-bob?format=html Position Statement Enteral Feed Tender- NHS Frimley and NHS BOB https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3694-position-statement-enteral-feed-tender-nhs-frimley-and-nhs-bob?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Thu, 13 Nov 2025 14:00:45 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3573-sermog-03-overarching-policy-on-switching-between-biosimilars?format=html SERMOG 03 Overarching policy on switching between biosimilars https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3573-sermog-03-overarching-policy-on-switching-between-biosimilars?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Wed, 10 Sep 2025 14:17:01 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3572-sermog-02-policy-on-licensed-doses-or-dosing-schedules-of-high-cost-drugs-not-considered-in-nice-technology-appraisal-ta-guidance?format=html SERMOG 02 Policy on licensed doses or dosing schedules of high cost drugs not considered in NICE Technology Appraisal (TA) guidance https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3572-sermog-02-policy-on-licensed-doses-or-dosing-schedules-of-high-cost-drugs-not-considered-in-nice-technology-appraisal-ta-guidance?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Wed, 10 Sep 2025 14:09:53 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3571-sermog-01-dual-biological-therapy-for-inflammatory-bowel-disease-in-adults?format=html SERMOG 01 Dual biological therapy for inflammatory bowel disease in adults https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3571-sermog-01-dual-biological-therapy-for-inflammatory-bowel-disease-in-adults?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Wed, 10 Sep 2025 14:07:55 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3329-026-mog-position-statement-hybrid-closed-loop-hcl-systems-for-managing-blood-glucose-levels-for-people-living-with-type-1-diabetes?format=html 026 MOG Position Statement- Hybrid closed loop (HCL) systems for managing blood glucose levels for people living with type 1 diabetes https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3329-026-mog-position-statement-hybrid-closed-loop-hcl-systems-for-managing-blood-glucose-levels-for-people-living-with-type-1-diabetes?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Fri, 09 May 2025 12:28:39 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3295-compact-oral-nutritional-supplements-ons-for-adults-sermog-04?format=html SERMOG 04 Compact oral nutritional supplements (ONS) for adults https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3295-compact-oral-nutritional-supplements-ons-for-adults-sermog-04?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Thu, 10 Apr 2025 14:46:55 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3158-025-mog-position-statement-attention-deficit-hyperactivity-disorder-adhd-diagnosis-and-management-for-cayp-oct-24?format=html 025 MOG Position Statement- Information required from provider by primary care when receiving a request to prescribe following referral to an ADHD service for children and young people (CAYP) https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/3158-025-mog-position-statement-attention-deficit-hyperactivity-disorder-adhd-diagnosis-and-management-for-cayp-oct-24?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Fri, 31 Jan 2025 12:57:46 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2581-003-mog-position-statement-conditions-for-which-over-the-counter-items-should-not-be-routinely-prescribed-april-24?format=html SERMOG-07 Over the counter (OTC) prescribing guidance https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2581-003-mog-position-statement-conditions-for-which-over-the-counter-items-should-not-be-routinely-prescribed-april-24?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Fri, 07 Jun 2024 14:30:29 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2578-024-mog-position-statement-prescribing-following-private-recommendation?format=html 024 MOG Position Statement - Prescribing following private recommendation https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2578-024-mog-position-statement-prescribing-following-private-recommendation?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Thu, 06 Jun 2024 12:20:49 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2567-023-safe-prescribing-of-short-acting-beta-agonists-saba-for-asthma?format=html 023 MOG Position Statement- Safe prescribing of short acting beta agonists (SABA) for asthma https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2567-023-safe-prescribing-of-short-acting-beta-agonists-saba-for-asthma?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Wed, 05 Jun 2024 15:56:42 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2388-022-mog-position-statement-safety-needles-and-safety-lancets?format=html 022 MOG Position Statement- Safety needles and safety lancets https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2388-022-mog-position-statement-safety-needles-and-safety-lancets?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Tue, 09 Apr 2024 12:39:28 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2058-005-mog-position-statement-prescribing-guidance-for-patients-travelling-abroad-1?format=html 005 MOG Position Statement- Prescribing guidance for patients travelling abroad https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2058-005-mog-position-statement-prescribing-guidance-for-patients-travelling-abroad-1?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Fri, 03 Nov 2023 14:43:03 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2057-021-mog-position-statement-request-to-prescribe-following-a-referral-to-an-adult-adhd-service?format=html 021 MOG Position Statement- Request to prescribe following a referral to an ADULT ADHD service https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2057-021-mog-position-statement-request-to-prescribe-following-a-referral-to-an-adult-adhd-service?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Fri, 03 Nov 2023 14:16:57 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2047-019-mog-position-statement-continuous-glucose-monitoring-cgm-and-pregnancy?format=html 019 MOG Position Statement- Continuous Glucose Monitoring (CGM) and pregnancy https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2047-019-mog-position-statement-continuous-glucose-monitoring-cgm-and-pregnancy?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Wed, 01 Nov 2023 18:23:58 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2043-018-mog-position-statement-generics-and-biosimilar-prescribing?format=html 018 MOG Position Statement- Generics and biosimilar prescribing https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/2043-018-mog-position-statement-generics-and-biosimilar-prescribing?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Wed, 01 Nov 2023 15:06:59 +0000 https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/1969-017-mog-position-statement-methotrexate-10mg-tablets?format=html 017 MOG Position Statement- Methotrexate 10mg tablets https://icb-archive.frimley.icb.nhs.uk/policies-and-documents/medicines-optimisation/prescribing-policies/1969-017-mog-position-statement-methotrexate-10mg-tablets?format=html sarah.sneath@nhs.net (Sarah Sneath) Position Statements Wed, 20 Sep 2023 14:38:56 +0000